Mulmit

ADMA BIOLOGICS, INC.ADMA BIOLOGICS, INC.

ADMA Nasdaq

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2025-12-31510,173,000191,443,000146,930,0000.6
2024-12-31426,454,000138,983,000197,700,0000.81
2023-12-31258,215,00021,632,000-28,200,000-0.13
2022-12-31154,080,000-39,365,000-65,900,000-0.33
2021-12-3180,943,000-58,374,000-71,650,000-0.51

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-07-24Kestenberg-Messina Kaitlin M.COO and SVP, Compliance3,177
2026-07-16Kohler TerryCFO and Treasurer85,130
2026-07-16Kohler TerryCFO and Treasurer136,363
2026-05-27Grossman Jerrold B6,400
2026-05-12Grossman Jerrold B12,500
2026-05-11Grossman Jerrold B12,500
2026-04-01Kestenberg-Messina Kaitlin M.COO and SVP, Compliance20,362
2026-03-17Guiheen Lawrence P.30,000
2026-03-17Guiheen Lawrence P.30,000
2026-03-16Grossman Adam SPresident and CEO15,000
2026-03-16Grossman Adam SPresident and CEO15,000
2026-03-16Grossman Adam SPresident and CEO6,000

8-K events

FiledItems
2026-08-05Results of operations · Financial statements and exhibits
2026-06-02Submission of matters to a vote
2026-05-06Results of operations · Financial statements and exhibits
2026-05-04Other events · Financial statements and exhibits
2026-03-27Regulation FD disclosure · Financial statements and exhibits
2026-03-02Regulation FD disclosure · Other events · Financial statements and exhibits
2026-02-25Results of operations · Officer or director change · Financial statements and exhibits
2026-01-12Results of operations · Regulation FD disclosure · Financial statements and exhibits
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…

Biological Products, (No Diagnostic Substances) — 같은 업종, 그리고 규모가 비슷한 기업Biological Products, (No Diagnostic Substances) — and other companies of a similar size

SEC가 같은 업종(Biological Products, (No Diagnostic Substances))으로 분류한 기업이 먼저 오고, 그다음은 제출된 매출로 가까운 순입니다 — 가장 최근 연간 값이며, 연간 값이 없으면 최근 네 분기 합입니다. Companies the SEC assigns to the same industry (Biological Products, (No Diagnostic Substances)) come first, then the nearest by revenue as filed — the latest annual figure, or the last four quarters where no annual one is filed. 순서일 뿐 값이 싸거나 비싸다는 뜻이 아닙니다.Order only — it does not say a company is cheap or expensive.